期刊文献+

HBVS-ecdCD40L融合基因构建及相应融合蛋白的二级结构预测

Construction of HBV S-ecdCD40L fusion gene and prediction of secondary structure of the fusion protein.
下载PDF
导出
摘要 目的构建HBVS—ecdCD40L融合基因,并利用软件对其相应融合蛋白的二级结构进行预测。方法利用分子生物学技术将HBVS基因与人CD40L胞外段基因进行融合,构建融合基因及其真核表达载体,并利用蛋白质分析软件对相应融合蛋白二级结构水平的一些生物学特性进行预测。结果融合基因序列与设计一致,其相应氨基酸序列经软件分析,并与HBsAg和CD40L胞外段氨基酸序列分析结果比较,发现在二级结构上几乎无变化,亲水性和抗原性等生物学活性几乎未受影响。结论HBVS-ecdCD40L融合基因构建成功,软件分析表明融合过程未影响HBsAg和人CD40L胞外段的生物学活性,为进一步研究奠定基础。 Objective To construct the HBV S-ecdCD40L fusion gene and to predict the secondary structure of the fusion protein. Methods The HBV S gene and the cDNA of extracellular domain of human CD40 ligand were linked by using PCR cloning. The protein analysis software was applied to predict the flexibility, hydrophilicity, antigenicity of the fusion protein. Results The software analysis demonstrated that the secondary structure of HBsAg and ecdCD40L was not changed after fusion and remained their biological activities. Conclusion The fusion gene containing HBV S gene and ecdCD40L gene was constructed successfully.
出处 《浙江医学》 CAS 2009年第4期463-465,共3页 Zhejiang Medical Journal
基金 浙江省自然科学基金资助项目(Y205445)
关键词 乙型肝炎 CD40配体 基因融合 Hepatitis B CD40 ligand Gene fusion
  • 相关文献

参考文献3

  • 1Van D M,Sprengers D,Binda R S,et al.Functional Impairment of myeloid and plasmacytold dendritic cells of patients with chronic hepatitis B[J].Hepato logy,2004,40:738-746.
  • 2黄茵,陈智,贾红宇,吴炜,蔡玲斐,周承.HBSAg基因修饰的树突状细胞诱导HBV转基因小鼠的免疫应答[J].中华传染病杂志,2006,24(5):306-310. 被引量:3
  • 3Li X Z,Yu C T,Hakan A,et al.An adenoviral vector cancer vaccine that delivers a tumor-associated antigen-CD40 ligand fusion protein to dendritic cells[J].PNAS,2003,100:15101-15106.

二级参考文献8

  • 1黄茵,陈智,贾红宇,蔡玲斐.HBsAg重组腺病毒载体的构建及在树突状细胞的表达[J].浙江预防医学,2006,18(6):1-3. 被引量:3
  • 2黄茵,陈智,贾红宇,吴伟,蔡玲斐,周承.HBsAg重组腺病毒转染的树突状细胞诱导BALB/c小鼠抗HBV免疫的研究[J].中华微生物学和免疫学杂志,2006,26(6):553-559. 被引量:2
  • 3van der Molen RG,Sprengers D,Binda RS,et al.Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.Hepatology,2004,40:738-746.
  • 4Shimizu Y,Guidotti LG,Fowler P,et al.Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.J Immunol,1998,161:4520-4529.
  • 5Akbar SM,Furukawa S,Hasebe A,et al.Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.Int J Mol Med,2004,14:295-299.
  • 6Mochizuki K,Hayashi N,Hiramatsu N,et al.Fas antigen expression in liver tissues of patients with chronic hepatitis B.J Hepatol,1996,24:1-7.
  • 7Tuettenberg A,Jonuleit H,Tuting T,et al.Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumorspecific CD8+ T cells:implications for an efficient vaccination strategy.Gene Ther,2003,10:243-250.
  • 8邢利和,王福生,刘明旭,朱传琳,李捍卫,雷周云,王慧芬,张冰,金磊.慢性乙型肝炎患者树突状细胞的培养鉴定和功能特点[J].中华传染病杂志,2001,19(6):348-351. 被引量:45

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部